Look for Drugs and Conditions

Fludrocortisone Acetate

Fludrocortisone Acetate

Fludrocortisone acetate is a synthetic corticosteroid with potent mineralocorticoid activity and some glucocorticoid effects. It is typically prescribed in oral tablet form and is known for its ability to enhance sodium reabsorption and potassium excretion in the kidneys.

Indications

Partial replacement therapy for primary and secondary aderenocortical insuffciency in addison's disease and for treatment of salt losing adernogenital syndrome.


Dosage

-Adults: Typically, the initial dose ranges from 0.1 to 0.2 mg per day, depending on the severity of the condition. The dose may be adjusted based on patient response and blood pressure levels . -Children: The dosage must be individualized according to age, weight, and specific medical needs.


Contra-Indications

-Adrenal Insufficiency: Used in the management of adrenal insufficiency, such as in Addison's disease, to help maintain electrolyte balance. -Orthostatic Hypotension: Prescribed for certain cases of orthostatic hypotension when non-drug measures are ineffective.


Special Precautions

-Cardiovascular Conditions: Care should be taken when using fludrocortisone acetate in patients with heart failure, hypertension, or other heart conditions. -Electrolyte Imbalance: The drug may cause fluid retention, leading to edema and imbalances in sodium and potassium levels. -Infections: It may mask signs of infection, so careful monitoring is required. Bone Health: Prolonged use may impact bone density, increasing the risk of osteoporosis.


Side Effects

Fluid retention and edema Hypokalemia (low potassium levels) Hypertension (high blood pressure) Weight gain Headache


Drug Interactions

-Diuretics: Increased risk of hypokalemia and blood pressure changes. -Antihypertensives: May reduce the effectiveness of these medications. -CYP3A4 inhibitors: May increase the levels and effects of fludrocortisone acetate.


Other Brands With Same Generic
Brand Name Manufactured by
FLORICOT SAMARTH PHARMA
Minocort Troikaa Pharmaceuticals Ltd
Ad 5